The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Comparison of extended versus brief treatments for marijuana use.
Stephens, R. S., Roffman, R. A., & Curtin, L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.898 · Cited by 711
The St. Mary's Hospital Sleep Questionnaire: A Study of Reliability
Ellis, B. W., Johns, M. W., Lancaster, R., Raptopoulos, P., Angelopoulos, N., & Priest, R. G. (1981) · Sleep · doi:10.1093/sleep/4.1.93 · Cited by 379
Abstinence symptoms following smoked marijuana in humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050849 · Cited by 353
Self-citationMarijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348 · cited 1×
“%) reported using marijuana to alleviate withdrawal symptoms (Budney et al, 1999).”
BackgroundA randomized controlled trial of brief cognitive–behavioral interventions for cannabis use disorder
Copeland, J., Swift, W., Roffman, R., & Stephens, R. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00179-9 · Cited by 322 · cited 1×
“Failure to quit is borne out by clinical studies, demonstrating that marijuana users have high rates of relapse comparable to those found for other drugs of abuse (Copeland et al, 2001; Stephens et al, 1994, 2000).”
ResultBudney, A. J., Higgins, S. T., Radonovich, K. J., & Novy, P. L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.1051 · Cited by 318
Donovan, S. J., Stewart, J. W., Nunes, E. V., Quitkin, F. M., Parides, M., Daniel, W., Susser, E., & Klein, D. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.818 · Cited by 273 · cited 2×
“The rationale for testing divalproex in Study 2 was that it has been used to treat irritability, mood lability, and temper outbursts (Donovan et al, 2000; Giakas et al, 1990), which are similar to symptoms of marijuana withdrawal.”
BackgroundMethodTreating adult marijuana dependence: A test of the relapse prevention model.
Stephens, R. S., Roffman, R. A., & Simpson, E. E. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.1.92 · Cited by 270
Abstinence symptoms following oral THC administration to humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050848 · Cited by 261
Self-citation
Cited by
DSM-5 criteria for substance use disorders: recommendations and rationale
Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060782 · Cited by 1,622
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Greenfield, S. F., Back, S. E., Lawson, K., & Brady, K. T. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.01.004 · Cited by 602
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
“Since then, preclinical (Copersino et al, 2006; Goldstein and Volkow, 2011; Haney et al, 2004; Martinez et al, 2007), clinical (Agrawal et al, 2008; Budney and Hughes, 2006; Budney et al, 2004; Chung et al, 2008; Copersino et al, 2006; Goldstein and Volkow, 2011; Hasin et al, 2008; Martinez et al,…”
BackgroundCannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Review of the Validity and Significance of Cannabis Withdrawal Syndrome
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1967 · Cited by 522
Cannabis and anxiety: a critical review of the evidence
Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509
Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI
Wernig, A. (2006) · Neurology · doi:10.1212/01.wnl.0000249079.73112.38 · Cited by 413
Angarita, G. A., Emadi, N., Hodges, S., & Morgan, P. T. (2016) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0056-7 · Cited by 358
The cannabis withdrawal syndrome
Budney, A. J., & Hughes, J. R. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218592.00689.e5 · Cited by 349
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“There are two small randomised, double-blind placebo-controlled trials of oral tetrahydrocannabinol (THC) (Budney et al., 2007; Haney et al., 2004) (Ib) which reduced withdrawal symptoms, including reduction in sleep problems and anxiety.”
BackgroundEffect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana
Schierenbeck, T., Riemann, D., Berger, M., & Hornyak, M. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.12.004 · Cited by 291
Marijuana Dependence and Its Treatment
Budney, A., Roffman, R., Stephens, R., & Walker, D. (2007) · Addiction Science & Clinical Practice · doi:10.1151/ascp07414 · Cited by 275
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3947 · Cited by 266
Cannabinoid tolerance and dependence: A review of studies in laboratory animals
GONZALEZ, S., CEBEIRA, M., & FERNANDEZRUIZ, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.028 · Cited by 258
Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.010 · Cited by 232
Reliability and validity of a short form of the Marijuana Craving Questionnaire
Heishman, S. J., Evans, R. J., Singleton, E. G., Levin, K. H., Copersino, M. L., & Gorelick, D. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.12.010 · Cited by 212
Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.367 · Cited by 206
“Participants completed a 44-item scale assessing a range of affective and physical symptoms capturing effects, eg, friendly, mellow, sedated, anxious (eg, Haney et al, 2004).”
BackgroundSelf-citationOral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A., & Bahrenburg, B. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.014 · Cited by 180
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed205 · Cited by 184
Self-citationReed, S. C., Levin, F. R., & Evans, S. M. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.02.018 · Cited by 170
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper, Z. D., & Haney, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00095.x · Cited by 158
Self-citationPharmacotherapies for cannabis dependence.
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub2 · Cited by 156
Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood
Haney, M., Rabkin, J., Gunderson, E., & Foltin, R. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2242-2 · Cited by 126
Self-citationExisting and future drugs for the treatment of the dark side of addiction
Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103143 · Cited by 121
Davis, M. L., Powers, M. B., Handelsman, P., Medina, J. L., Zvolensky, M., & Smits, J. A. J. (2015) · Evaluation & the Health Professions · doi:10.1177/0163278714529970 · Cited by 114
Levin, F. R., Mariani, J. J., Pavlicova, M., Brooks, D., Glass, A., Mahony, A., Nunes, E. V., Bisaga, A., Dakwar, E., Carpenter, K. M., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.11.025 · Cited by 109
Crippa, J. A. S., Hallak, J. E. C., Machado-de-Sousa, J. P., Queiroz, R. H. C., Bergamaschi, M., Chagas, M. H. N., & Zuardi, A. W. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12018 · Cited by 101
“Low doses of D(9)-THC with no significant intoxication effects were found to improve abstinence symptoms.(8,9) Nevertheless, even low doses such as the ones used in these studies have reinforcing properties in chronic cannabis users, suggesting that THC-based treatment does not preclude the possibility of abuse.”
BackgroundEffects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
Trigo, J. M., Lagzdins, D., Rehm, J., Selby, P., Gamaleddin, I., Fischer, B., Barnes, A. J., Huestis, M. A., & Le Foll, B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.020 · Cited by 97
“It is unclear if CBD is needed to offset cannabis withdrawal, as positive effects were reported with both oral THC at different doses (30–90 mg/day; Budney et al., 2007b; Haney et al., 2004) and with Sativex at daily doses of 86.4 mg THC and 80 mg CBD (Allsop et al., 2014).”
BackgroundInfluentialPharmacotherapies for cannabis dependence
Nielsen, S., Gowing, L., Sabioni, P., & Le Foll, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub3 · Cited by 96
Bedi, G., Cooper, Z. D., & Haney, M. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00427.x · Cited by 83
Self-citationHaney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., & Cooper, Z. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.108 · Cited by 73
Self-citationOpioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper, Z. D., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1875-y · Cited by 58
Self-citationWeinstein, A. M., Miller, H., Bluvstein, I., Rapoport, E., Schreiber, S., Bar-Hamburger, R., & Bloch, M. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.819362 · Cited by 53
Spanagel, R., & Bilbao, A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108680 · Cited by 43
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers
Haney, M., Cooper, Z. D., Bedi, G., Herrmann, E., Comer, S. D., Reed, S. C., Foltin, R. W., & Levin, F. R. (2019) · Addiction Biology · doi:10.1111/adb.12621 · Cited by 31
“Subjective ratings of the previous night’s sleep were obtained using a 7-item VAS sleep questionnaire completed each morning (Haney et al. 2004).”
MethodSelf-citationCharacteristics of clinically anxious versus non-anxious regular, heavy marijuana users
Van Dam, N. T., Bedi, G., & Earleywine, M. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.05.021 · Cited by 26
Metadata
- Authors
- Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J., Bennett, A., Zubaran, C., & Foltin, R. W.
- Venue
- Neuropsychopharmacology
- Published
- 2003-10-15
- Volume
- 29
- Issue
- 1
- Pages
- 158-170
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1986135283
- Cited by
- 264
- References
- 37
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.